A detailed history of Baader Bank Aktiengesellschaft transactions in United Therapeutics Corp stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 2,660 shares of UTHR stock, worth $956,482. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,660
Previous 1,526 74.31%
Holding current value
$956,482
Previous $486,000 96.09%
% of portfolio
0.06%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$311.04 - $363.55 $352,719 - $412,265
1,134 Added 74.31%
2,660 $953,000
Q2 2024

Jul 17, 2024

BUY
$228.26 - $319.04 $348,324 - $486,855
1,526 New
1,526 $486,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.